DaVita Inc. (DVA) Return on Assets (ROA): 4.47%
Is DaVita Inc.’s return on assets (ROA) high or low?
DaVita Inc.'s return on assets (ROA) of 4.47% is in line with its 5-year average of 4.56%, around the middle of its 5-year range (3.31%–5.71%).
As of Tuesday, June 16, 2026. 7.74% below its 12-month average of 4.84%.
DVA Return on Assets (ROA) Chart
DVA Average Return on Assets (ROA) Chart
DVA Current vs Average Return on Assets (ROA) Chart
DVA Return on Assets (ROA) Metrics
RETURN ON ASSETS (ROA)
4.47%
RETURN ON ASSETS (ROA) AVG TTM
4.84%
RETURN ON ASSETS (ROA) AVG 3Y
4.27%
RETURN ON ASSETS (ROA) AVG 5Y
4.56%
RETURN ON ASSETS (ROA) AVG 10Y
3.86%
RETURN ON ASSETS (ROA) AVG 15Y
4.41%
RETURN ON ASSETS (ROA) AVG 20Y
4.37%
CURRENT VS TTM AVG
-7.74%
CURRENT VS 3Y AVG
+4.62%
CURRENT VS 5Y AVG
-1.94%
CURRENT VS 10Y AVG
+15.67%
CURRENT VS 15Y AVG
+1.48%
CURRENT VS 20Y AVG
+2.22%
DVA Competitors' Return on Assets (ROA)
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DaVita Inc. (DVA) | $13.42B | 4.47% | 4.84% | 4.27% | 4.56% |
| Solventum Corporation (SOLV)vs › | $13.26B | 10.16% | 7.10% | 8.43% | 7.35% |
| The Cooper Companies, Inc. (COO)vs › | $13.22B | 1.89% | 3.10% | 3.02% | 7.71% |
| Medpace Holdings, Inc. (MEDP)vs › | $13.18B | 21.62% | 21.05% | 19.32% | 16.45% |
| Align Technology, Inc. (ALGN)vs › | $12.92B | 6.81% | 6.68% | 6.69% | 12.75% |
| Revvity, Inc. (RVTY)vs › | $11.29B | 2.01% | 2.19% | 1.89% | 3.83% |
| Baxter International Inc. (BAX)vs › | $10.57B | -5.53% | -3.64% | -1.62% | 0.47% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -9.07% | -6.92% | -1.48% | 0.07% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 5.92% | 7.45% | 8.56% | 11.79% |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.99B | -2.39% | -0.94% | 2.58% | 3.75% |
Asset Efficiency
ROA
4.5%
ROE
-114.7%
DaVita Inc. Return on Assets (ROA) Formula & Definition
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
DaVita Inc. Return on Assets (ROA) FAQ
- What is the return on assets (ROA) for DaVita Inc. (DVA)?
- The return on assets (ROA) for DVA stock is 4.47%.
- Is DaVita Inc.'s return on assets (ROA) high or low?
- DaVita Inc.'s return on assets (ROA) of 4.47% is in line with its 5-year average of 4.56%, around the middle of its 5-year range (3.31%–5.71%).
- What is the TTM average return on assets (ROA) for DaVita Inc. (DVA)?
- The TTM average return on assets (ROA) for DVA stock is 4.84%.
- What is the 3Y average return on assets (ROA) for DaVita Inc. (DVA)?
- The 3Y average return on assets (ROA) for DVA stock is 4.27%.
- What is the 5Y average return on assets (ROA) for DaVita Inc. (DVA)?
- The 5Y average return on assets (ROA) for DVA stock is 4.56%.
- What is the 10Y average return on assets (ROA) for DaVita Inc. (DVA)?
- The 10Y average return on assets (ROA) for DVA stock is 3.86%.
- What is the 15Y average return on assets (ROA) for DaVita Inc. (DVA)?
- The 15Y average return on assets (ROA) for DVA stock is 4.41%.
- What is the 20Y average return on assets (ROA) for DaVita Inc. (DVA)?
- The 20Y average return on assets (ROA) for DVA stock is 4.37%.
DaVita Inc. Return on Assets (ROA) History
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 4.27% |
| 2024-12-31 | 5.42% |
| 2023-12-31 | 4.09% |
| 2022-12-31 | 3.31% |
| 2021-12-31 | 5.71% |
| 2020-12-31 | 4.55% |
| 2019-12-31 | 4.68% |
| 2018-12-31 | 0.83% |
| 2017-12-31 | 3.50% |
| 2016-12-31 | 4.69% |
| 2015-12-31 | 1.46% |
| 2014-12-31 | 4.03% |
| 2013-12-31 | 3.70% |
| 2012-12-31 | 3.34% |
| 2011-12-31 | 5.38% |
| 2010-12-31 | 5.00% |
| 2009-12-31 | 5.59% |
| 2008-12-31 | 5.14% |
| 2007-12-31 | 5.50% |
| 2006-12-31 | 4.46% |
| 2005-12-31 | 3.64% |
| 2004-12-31 | 8.85% |
| 2003-12-31 | 9.04% |
| 2002-12-31 | 8.86% |
| 2001-12-31 | 8.26% |
| 2000-12-31 | 0.84% |
| 1999-12-31 | -7.16% |
| 1998-12-31 | -0.49% |
| 1997-12-31 | 6.54% |
| 1996-12-31 | 7.14% |
Related Metrics
About DaVita Inc.
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Javier J. Rodriguez